Hydrogel-based ocular drug delivery systems for hydrophobic drugs

被引:77
作者
Torres-Luna, Cesar [1 ]
Fan, Xin [2 ]
Domszy, Roman [3 ]
Hu, Naiping [3 ]
Wang, Nam Sun [1 ]
Yang, Arthur [3 ]
机构
[1] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA
[2] Auburn Univ, Dept Chem Engn, Auburn, AL 36849 USA
[3] Lynthera Corp, Lancaster, PA 17601 USA
关键词
Ocular drug delivery; Hydrogels; Controlled release; Biomaterials; Hydrophobic drugs; Soft contact lenses; CHITOSAN THERMOSENSITIVE HYDROGEL; SOFT CONTACT-LENSES; HUMAN AQUEOUS-HUMOR; SILICONE-HYDROGEL; PROSTAGLANDIN ANALOGS; CYCLOSPORINE-A; BETA-CYCLODEXTRIN; OPHTHALMIC DELIVERY; SUSTAINED-RELEASE; EXTENDED DELIVERY;
D O I
10.1016/j.ejps.2020.105503
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Conventional ophthalmic dosage forms such as eye drops pose a significant challenge because physiological barriers and clearance mechanisms limit ocular bioavailability. Hydrogels are promising therapeutic materials for ocular drug delivery because of their high biocompatibility and their ability to hold and release therapeutic agents. Even though they are generally associated with the delivery of hydrophilic drugs, several approaches have been developed to integrate hydrophobic ophthalmic drugs into hydrogels. Because of the limitations associated with the traditional topical eye drop delivery of hydrophobic drugs, hydrogel-based systems represent a viable alternative for controlled ocular drug delivery. This review presents an overview on the ophthalmic applications of hydrogels for the delivery of hydrophobic drugs, with special focus on diseases occurring in the anterior segment of the eye. We summarize the key hydrogels for incorporation and delivery of hydrophobic drugs, including soft contact lenses (SCLs), stimuli-responsive hydrogels, cyclodextrin-based polymeric hydrogels, and nanoparticle-loaded hydrogels. The strategies of integrating hydrophobic drugs into hydrogels as discussed in this review provide significant potential in ocular therapeutics.
引用
收藏
页数:15
相关论文
共 170 条
[1]   In situ gel systems as 'smart' carriers for sustained ocular drug delivery [J].
Agrawal, Ashish Kumar ;
Das, Manasmita ;
Jain, Sanyog .
EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (04) :383-402
[2]  
Al-Badriyeh D, 2010, CLIN OPHTHALMOL, V4, P391
[3]  
Alberth M, 1991, J BIOPHARM SCI, V2, P115
[4]   Industrial perspective in ocular drug delivery [J].
Ali, Yusuf ;
Lehmussaari, Kari .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (11) :1258-1268
[5]  
Alvarez-Lorenzo C., 2006, Am J Drug Deliv, V4, P22
[6]  
Ames Philip, 2015, Clin Investig (Lond), V5, P267, DOI 10.4155/cli.14.135
[7]  
[Anonymous], **DATA OBJECT**
[8]  
[Anonymous], **DATA OBJECT**
[9]  
[Anonymous], **DATA OBJECT**
[10]  
[Anonymous], **DATA OBJECT**